ESTA
Establishment Labs Holdings Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-23/100
Last price
64.20
▼ 1.09 (1.67%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
65.30
Prev close
65.29
Day high
65.97
Day low
63.97
Volume
222.82K
Market cap
$1.91B
P/E (TTM)
—
52W range
38.38 – 97.59
Day trading desk
Gap from prior close
+0.02%
Prior close 65.29
VWAP
65.08
-1.35% from price
Relative volume
0.52×
Quiet session
Session range
3.13%
63.97 – 65.97
Position in range
11%
Near session low
ATR (14D)
2.70
4.20% of price
Prior day high
68.05
PDH
Prior day low
64.59
PDL
Bid / ask spread
—
Quote not published
Session volume
222.50K
Avg 426.60K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.05%
-1.8%
1M
-14.73%
-16.2%
3M
-27.68%
-31.0%
6M
+3.53%
-11.4%
YTD
-11.91%
-25.9%
1Y
+63.23%
+47.5%
3Y
+41.44%
-40.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on ESTA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-417.79K
Net selling
Buy transactions
15
45.82K shares
Sell transactions
7
463.61K shares
Net transactions
+22
Buys less sells
Sell : buy shares
10.1 : 1
Heavily one-sided
Insider-held shares
2.99M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 30, 26 | LEWIN NICHOLAS SHERIDAN Director |
STOCK | 389 | $24.96K | Direct |
| Jun 30, 26 | SCHUTTER EDWARD JAMES Director |
STOCK | 216 | $18.54K | Direct |
| Jun 30, 26 | LEWIN NICHOLAS SHERIDAN Director |
STOCK | 291 | $24.97K | Direct |
| Jun 30, 26 | CUSTIN ANN Director |
STOCK | 239 | $20.51K | Direct |
| Jun 30, 26 | SLOTKIN BRYAN Director |
STOCK | 189 | $16.22K | Direct |
| Jun 30, 26 | GILLIN LESLIE Director |
STOCK | 196 | $16.82K | Direct |
| Jun 24, 26 | HARRIS TAYLOR C Director |
STOCK | 3.23K | $0 | Direct |
| Jun 24, 26 | HARRIS TAYLOR C Director |
STOCK | 3.72K | $0 | Direct |
| May 28, 26 | JW ASSET MANAGEMENT, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
SELL | 90.53K | $6.64M | Indirect |
| May 22, 26 | SCHUTTER EDWARD JAMES Director |
STOCK | 2.35K | $0 | Direct |
| May 22, 26 | LEWIN NICHOLAS SHERIDAN Director |
STOCK | 2.35K | $0 | Direct |
| May 22, 26 | CUSTIN ANN Director |
STOCK | 2.35K | $0 | Direct |
| May 22, 26 | SLOTKIN BRYAN Director |
STOCK | 2.35K | $0 | Direct |
| May 22, 26 | GILLIN LESLIE Director |
STOCK | 2.35K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CALDINI FILIPPO |
Chief Executive Officer | 43.43K | Stock Award(Grant) |
CHACON QUIROS JUAN JOSE |
Director | — | Sale |
CUSTIN ANN |
Director | 24.32K | Stock Award(Grant) |
DENHOY RAJ |
Chief Financial Officer | 23.35K | Stock Award(Grant) |
GILLIN LESLIE |
Director | 18.59K | Stock Award(Grant) |
JW ASSET MANAGEMENT, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
LEWIN NICHOLAS SHERIDAN |
Director | 1.08M | Stock Award(Grant) |
MANSBACH SAMUEL ROSS |
General Counsel | 19.32K | Stock Award(Grant) |
SCHUTTER EDWARD JAMES |
Director | 177.95K | Stock Award(Grant) |
SLOTKIN BRYAN |
Director | 32.80K | Stock Award(Grant) |
Fundamentals
Market cap$1.91B
Enterprise value$2.14B
Revenue (TTM)$245.82M
Gross profit$173.27M
EBITDA$-8.98M
Net income$-38.89M
EPS (TTM)$-1.30
Free cash flow$-19.29M
Total cash$71.16M
Total debt$263.67M
Book value / share$0.73
Shares outstanding29.80M
Float19.53M
Short % of float18.39%
Dividend yield0.00%
Beta (5Y)1.06
Valuation & profitability ratios
Trailing P/E—
Forward P/E1,070.00
PEG ratio—
Price / sales—
Price / book88.55
EV / revenue8.70
EV / EBITDA-238.01
Gross margin70.49%
Operating margin-6.35%
Profit margin-15.82%
Return on equity-175.30%
Return on assets-3.44%
Debt / equity1,220.32
Current ratio3.84
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $211.08M | $166.03M | $165.15M | $161.70M | +27.1% |
| Operating revenue | $211.08M | $166.03M | $165.15M | $161.70M | +27.1% |
| Cost of revenue | $64.77M | $56.50M | $58.17M | $55.10M | +14.6% |
| Gross profit | $146.31M | $109.53M | $106.98M | $106.59M | +33.6% |
| Research & development | $20.25M | $19.71M | $26.43M | $20.27M | +2.7% |
| Selling, general & admin | $165.07M | $139.81M | $145.57M | $125.98M | +18.1% |
| Total operating expense | $185.32M | $159.51M | $172.00M | $146.25M | +16.2% |
| Operating income | -$39.01M | -$49.99M | -$65.03M | -$39.66M | +22.0% |
| Net interest income | -$24.83M | -$19.35M | -$14.37M | -$11.67M | -28.3% |
| Pre-tax income | -$58.02M | -$84.63M | -$78.58M | -$72.82M | +31.4% |
| Tax provision | -$6.96M | -$32.00K | -$81.00K | $2.38M | -21,643.8% |
| Net income | -$51.06M | -$84.60M | -$78.50M | -$75.21M | +39.6% |
| Net income to common | -$51.06M | -$84.60M | -$78.50M | -$75.21M | +39.6% |
| Basic EPS | -1.72 | -3.00 | -3.07 | -3.08 | +42.7% |
| Diluted EPS | -1.72 | -3.00 | -3.07 | -3.08 | +42.7% |
| EBIT | -$32.77M | -$63.80M | -$63.19M | -$61.06M | +48.6% |
| EBITDA | -$22.29M | -$56.22M | -$58.31M | -$56.73M | +60.4% |
| Basic shares | 29.62M | 28.16M | 25.60M | 24.46M | +5.2% |
| Diluted shares | 29.62M | 28.16M | 25.60M | 24.46M | +5.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $75.57M | $90.35M | $40.03M | $66.36M | -16.4% |
| Cash & short-term investments | $75.57M | $90.35M | $40.03M | $66.36M | -16.4% |
| Accounts receivable | $77.50M | $65.00M | $46.92M | $35.42M | +19.2% |
| Inventory | $85.61M | $78.77M | $79.47M | $36.58M | +8.7% |
| Total current assets | $249.94M | $243.04M | $174.90M | $149.90M | +2.8% |
| Property, plant & equipment | $79.95M | $83.59M | $80.59M | $54.79M | -4.3% |
| Goodwill & intangibles | $11.15M | $12.89M | $8.45M | $5.07M | -13.5% |
| Total assets | $357.17M | $346.83M | $268.64M | $211.06M | +3.0% |
| Total current liabilities | $82.14M | $68.28M | $57.15M | $38.96M | +20.3% |
| Current debt | $12.41M | — | — | — | — |
| Long-term debt | $247.52M | $219.58M | $188.74M | $175.46M | +12.7% |
| Total debt | $264.47M | $225.29M | $192.22M | $179.35M | +17.4% |
| Total liabilities | $333.62M | $293.74M | $250.25M | $219.25M | +13.6% |
| Retained earnings | -$495.76M | -$444.69M | -$360.10M | -$281.59M | -11.5% |
| Shareholder equity | $23.55M | $53.09M | $18.39M | -$8.19M | -55.7% |
| Working capital | $167.80M | $174.76M | $117.75M | $110.94M | -4.0% |
| Net tangible assets | $12.40M | $40.20M | $9.94M | -$13.26M | -69.2% |
| Shares issued | 29.71M | 29.20M | 26.50M | 24.82M | +1.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$51.06M | -$84.60M | -$78.50M | -$75.21M | +39.6% |
| Depreciation & amortisation | $10.47M | $7.58M | $4.88M | $4.34M | +38.2% |
| Stock-based compensation | $11.82M | $15.37M | $14.86M | $13.36M | -23.1% |
| Change in working capital | -$13.17M | -$15.50M | -$34.13M | -$21.54M | +15.0% |
| Operating cash flow | -$50.89M | -$58.52M | -$88.51M | -$52.17M | +13.0% |
| Capital expenditure | -$6.72M | -$15.56M | -$24.55M | -$34.27M | +56.8% |
| Investing cash flow | -$7.03M | -$15.61M | -$24.55M | -$34.79M | +55.0% |
| Financing cash flow | $40.43M | $125.89M | $86.23M | $100.25M | -67.9% |
| Free cash flow | -$57.61M | -$74.08M | -$113.06M | -$86.43M | +22.2% |
| End cash position | $75.57M | $90.35M | $40.03M | $66.36M | -16.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $67.54M | $59.88M | $64.62M | $53.78M | $51.30M | +12.8% |
| Operating revenue | $67.54M | $59.88M | $64.62M | $53.78M | $51.30M | +12.8% |
| Cost of revenue | $19.83M | $17.54M | $19.09M | $16.09M | $16.03M | +13.0% |
| Gross profit | $47.71M | $42.34M | $45.53M | $37.70M | $35.27M | +12.7% |
| Research & development | $5.10M | $5.24M | $5.43M | $4.55M | $5.20M | -2.8% |
| Selling, general & admin | $46.91M | $43.60M | $44.03M | $37.17M | $44.18M | +7.6% |
| Total operating expense | $52.00M | $48.85M | $49.46M | $41.72M | $49.38M | +6.5% |
| Operating income | -$4.29M | -$6.51M | -$3.93M | -$4.03M | -$14.11M | +34.1% |
| Net interest income | -$7.00M | -$7.06M | -$7.21M | -$6.16M | -$5.87M | +0.9% |
| Pre-tax income | -$11.74M | -$13.09M | -$11.91M | -$10.72M | -$15.59M | +10.3% |
| Tax provision | $6.00K | $288.00K | -$9.30M | $424.00K | $1.00M | -97.9% |
| Net income | -$11.75M | -$13.38M | -$2.62M | -$11.15M | -$16.59M | +12.2% |
| Net income to common | -$11.75M | -$13.38M | -$2.62M | -$11.15M | -$16.59M | +12.2% |
| Basic EPS | -0.39 | -0.45 | -0.09 | -0.38 | -0.57 | +13.3% |
| Diluted EPS | -0.39 | -0.45 | -0.09 | -0.38 | -0.57 | +13.3% |
| EBIT | -$4.71M | -$6.01M | -$4.67M | -$4.52M | -$9.63M | +21.6% |
| EBITDA | -$2.04M | -$3.31M | -$1.90M | -$1.98M | -$7.04M | +38.4% |
| Basic shares | 30.12M | 29.95M | 29.80M | 29.62M | 28.91M | +0.6% |
| Diluted shares | 30.12M | 29.95M | 29.80M | 29.62M | 28.91M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $71.16M | $68.10M | $75.57M | $70.62M | $54.64M | +4.5% |
| Cash & short-term investments | $71.16M | $68.10M | $75.57M | $70.62M | $54.64M | +4.5% |
| Accounts receivable | $75.65M | $77.08M | $77.50M | $71.44M | $70.09M | -1.9% |
| Inventory | $84.98M | $86.66M | $85.61M | $88.16M | $94.68M | -1.9% |
| Total current assets | $247.73M | $245.83M | $249.94M | $239.60M | $229.17M | +0.8% |
| Property, plant & equipment | $77.51M | $78.58M | $79.95M | $80.75M | $81.16M | -1.4% |
| Goodwill & intangibles | $10.64M | $10.51M | $11.15M | $11.61M | $12.39M | +1.2% |
| Total assets | $351.93M | $351.04M | $357.17M | $338.89M | $329.67M | +0.3% |
| Total current liabilities | $64.56M | $83.15M | $82.14M | $71.98M | $80.74M | -22.4% |
| Current debt | — | $11.24M | $12.41M | $10.00M | $5.00M | — |
| Long-term debt | $261.70M | $248.59M | $247.52M | $246.46M | $221.13M | +5.3% |
| Total debt | $263.67M | $263.96M | $264.47M | $261.16M | $231.12M | -0.1% |
| Total liabilities | $330.32M | $336.25M | $333.62M | $322.53M | $306.90M | -1.8% |
| Retained earnings | -$520.89M | -$509.14M | -$495.76M | -$493.14M | -$482.00M | -2.3% |
| Shareholder equity | $21.61M | $14.78M | $23.55M | $16.36M | $22.76M | +46.2% |
| Working capital | $183.17M | $162.67M | $167.80M | $167.62M | $148.43M | +12.6% |
| Net tangible assets | $10.97M | $4.27M | $12.40M | $4.75M | $10.37M | +156.8% |
| Shares issued | 29.79M | 29.79M | 29.71M | 29.46M | 29.38M | -0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$11.75M | -$13.38M | -$2.62M | -$11.15M | -$16.59M | +12.2% |
| Depreciation & amortisation | $2.67M | $2.69M | $2.77M | $2.54M | $2.60M | -0.9% |
| Stock-based compensation | $3.13M | $3.10M | $3.00M | $2.99M | $3.28M | +1.1% |
| Change in working capital | -$16.74M | $1.07M | $3.77M | -$9.20M | -$2.55M | -1,659.0% |
| Operating cash flow | -$16.60M | -$4.31M | -$162.00K | -$11.25M | -$18.75M | -285.2% |
| Capital expenditure | -$3.65M | -$1.96M | -$1.66M | -$1.96M | -$2.07M | -86.2% |
| Investing cash flow | -$3.65M | -$1.96M | -$1.66M | -$1.96M | -$2.07M | -86.2% |
| Financing cash flow | $23.46M | -$864.00K | $6.05M | $29.45M | $5.13M | +2,815.6% |
| Free cash flow | -$20.25M | -$6.27M | -$1.82M | -$13.21M | -$20.82M | -223.0% |
| End cash position | $71.16M | $68.10M | $75.57M | $70.62M | $54.64M | +4.5% |
Options analytics
Put / call volume
22.03
Put-heavy session
Put / call open interest
1.93
Positioning, not flow
Max pain
70.00
+9.0% from spot
ATM implied vol
56.3%
Nearest strike to spot
Skew (10% OTM)
-20.3%
Calls bid over puts
Call volume
66
Contracts, this expiry
Put volume
1.45K
Contracts, this expiry
Heaviest call OI
72.50
428 contracts
Heaviest put OI
65.00
903 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.31 | -0.32 | -4.2% |
| Mar 2026 | -0.38 | -0.40 | -4.6% |
| Dec 2025 | -0.22 | -0.09 | +58.1% |
| Sep 2025 | -0.51 | -0.38 | +26.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.23 | 2 | $66.79M | +24.2% |
| Next quarter | -0.04 | 2 | $75.99M | +17.6% |
| Current year | -1.10 | 2 | $270.18M | +28.0% |
| Next year | 0.06 | 2 | $339.21M | +25.6% |
Analyst targets & ownership
Mean target$102.44
High target$117.00
Low target$92.00
Implied upside59.57%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy2 / 7
Hold0
Sell / Strong sell0 / 0
Held by insiders10.04%
Held by institutions105.81%
Institutions holding270
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
64.78
-0.90% from price
SMA 20
67.47
-4.84% from price
SMA 50
73.66
-12.84% from price
SMA 100
78.15
-17.85% from price
SMA 200
73.13
-12.22% from price
EMA 12
65.79
-2.42% from price
EMA 26
68.47
-6.23% from price
EMA 50
72.06
-10.91% from price
RSI (14)
37.6
Neutral
MACD (12,26,9)
-2.68
Hist 0.14
ATR (14)
2.70
4.20% of price
Realised vol 30D
39.2%
Annualised
Bollinger upper
73.39
20, 2σ
Bollinger lower
61.54
20, 2σ
50 / 200 cross
Golden
73.66 vs 73.13
Trend bias
Below 200
-12.22%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.30
More volatile than market
Correlation to SPY
0.31
Loosely linked
Realised vol 30D
39.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-34.1%
Peak to trough
Max drawdown 5Y
-74.3%
Peak to trough
ATR 14
2.70
4.20% of price
Beta (reported)
1.06
5Y monthly, from filing
Short interest
Shares short
4.39M
Prior 4.10M
Change vs prior
+7.0%
Shorts adding
% of float
18.39%
Elevated
% of shares out
14.72%
Against total outstanding
Days to cover
12.3
Crowded exit
Float
19.53M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 1, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 13, 26 | Citigroup | UPGRADE | Neutral | Buy |
| Aug 7, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 6, 26 | Needham | MAINTAINED | Buy | Buy |
| Aug 6, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 3, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 15, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 8, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| May 7, 26 | BTIG | MAINTAINED | Buy | Buy |
| Apr 29, 26 | BTIG | MAINTAINED | Buy | Buy |
| Mar 11, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Feb 26, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-29
Corporate Changes & Voting Matters
8-K · 2026-05-22
Periodic Financial Reports
10-Q · 2026-05-08
Corporate Changes & Voting Matters
8-K · 2026-05-06
Corporate Changes & Voting Matters
8-K · 2026-04-30
Proxy Statements
DEFA14A · 2026-04-24
Headlines
Establishment Labs Holdings (ESTA) Wins Expanded FDA Clearance, Is The Stock Still A Bargain?
Simply Wall St. · 13h ago
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®
Business Wire · 2d ago
Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity?
Insider Monkey · 14d ago
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
Business Wire · 16d ago
Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.
MarketWatch · 29d ago
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
CNW Group · 36d ago
Citigroup Upgrades Establishment Labs to Buy From Neutral, Price Target is $92
MT Newswires · 55d ago
Baron Discovery Fund’s Strategic Trim of Establishment Labs Holdings Inc (ESTA) Locks Gains
Insider Monkey · 56d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.